Skeletal muscle generated from induced pluripotent stem cells - induction and application.

Area of Science:

• Biomedical Engineering
• Stem Cell Biology
• Regenerative Medicine

Background:

• Human induced pluripotent stem cells (hiPSCs) can be generated from patients with severe muscle diseases.
• Skeletal muscle derived from patient-iPSCs exhibiting disease-specific phenotypes is valuable for pathogenesis research and drug development.

Purpose of the Study:

• To explore the utility of patient-derived hiPSCs for understanding muscle disease mechanisms.
• To evaluate the potential of hiPSC-derived skeletal muscle for therapeutic applications, including cell therapy and drug discovery.

Main Methods:

• Derivation of skeletal muscle from human induced pluripotent stem cells (hiPSCs).
• Generation of hiPSCs from patients with severe muscle diseases.
• Genome editing of hereditary muscle disease-iPSCs to express normal proteins.

Main Results:

• Patient-iPSC-derived skeletal muscle can display disease-specific phenotypes, aiding in pathogenesis studies.
• hiPSCs from healthy donors or gene-corrected iPSCs represent a potential source for cell therapy.

Conclusions:

• Advancements in hiPSC technology are crucial for developing effective treatments for devastating muscle diseases.
• Future research focuses on establishing mature myofibers for disease modeling, high-throughput drug screening, and large-scale preparation of regenerative cells for transplantation.